Search

Search Constraints

You searched for: Is Part Of Allergy. Volume 73:Issue 4(2018)

Search Results

1. A randomized, double‐blind, placebo‐controlled, dose‐finding trial with Lolium perenne peptide immunotherapy. Issue 4 (22nd December 2017)

2. Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project. Issue 4 (10th January 2018)

3. Blocking antibodies induced by allergen‐specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model. Issue 4 (22nd December 2017)

4. Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy. Issue 4 (12th December 2017)

7. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Issue 4 (30th October 2017)

8. EAACI guidelines on allergen immunotherapy: Executive statement. Issue 4 (16th April 2018)

9. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy. Issue 4 (5th December 2017)

10. EAACI Guidelines on allergen immunotherapy: IgE‐mediated food allergy. Issue 4 (5th December 2017)